User:Tkadm30/Notebook/Endocannabinoids/2-AG: Difference between revisions
From OpenWetWare
(→Notes) |
|||
Line 9: | Line 9: | ||
===Notes=== | ===Notes=== | ||
Astrocytes-induced synaptogenesis is enhanced by synaptic retrograde signaling. Thus homeostatic plasticity is increased by endogenous cannabinoid mobilization. | |||
===Results=== | ===Results=== | ||
2-AG exert neuroprotective effects on excitotoxic brain injury. | 2-AG exert neuroprotective effects on excitotoxic brain injury. | ||
===See also=== | ===See also=== | ||
* [[User:Etienne_Robillard/Notebook/Phospholipase_C|Phospholipase C Notebook]] | * [[User:Etienne_Robillard/Notebook/Phospholipase_C|Phospholipase C Notebook]] |
Revision as of 07:24, 8 October 2015
2-arachidonoylglycerol (2-AG)
Synopsis
A novel gliotransmitter controlled by the P2X7 receptor;
2-AG is an endogenous cannabinoid ligand synthesized by diacylglycerol lipase (DGL-α) and phospholipase C (PLC).
Notes
Astrocytes-induced synaptogenesis is enhanced by synaptic retrograde signaling. Thus homeostatic plasticity is increased by endogenous cannabinoid mobilization.
Results
2-AG exert neuroprotective effects on excitotoxic brain injury.